Judge Eldon Fallon of the U.S. District Court for the Eastern District of Louisiana has assigned early 2017 trial dates for the first four federal Xarelto lawsuits, Reuters reports. Currently, over 1,700 Xarelto bleeding lawsuits are pending in the Louisiana Xarelto MDL.
Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011 for use as an anticoagulant in certain patients at risk for embolic events. ...
continue reading...The number of Xarelto lawsuits in federal court jumped by nearly 500 over the month of August. There are currently over 1,700 Xarelto lawsuits consolidated in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana, and if recent court records are anything to go by, the number will continue to increase rapidly in the coming months.
Xarelto is a blood-thinning drug approved by ...
continue reading...Over 1,200 Xarelto lawsuits are pending in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana. Xarelto plaintiffs allege that the anticoagulant drug’s manufacturers, including Bayer HealthCare Pharmaceuticals and Johnson & Johnson’s Janssen Pharmaceutical, did not provide patients and doctors with adequate warning about Xarelto’s severe bleeding risks.
Approved by the U.S. Food and Drug Administration (FDA) in ...
continue reading...
An Indiana man has filed a Xarelto lawsuit alleging Janssen Pharmaceutica’s popular blood thinner caused him to experience severe bleeding. The new Xarelto lawsuit will join hundreds of similar cases centralized late last year in the U.S. District Court for the Eastern District of Louisiana.
Xarelto was approved by the U.S. Food and Drug Administration in 2011 to help prevent blood clotting in patients who have undergone surgery ...
continue reading...A new study has been published by the Journal of the American Medical Association Opthalmology linking use of the anticoagulant Xarelto (rivaroxaban) to eye bleeding. The study, conducted by Retina Associates of Orange County in Laguna Hills, California, observes three patients who developed spontaneous vitreous hemorrhage after starting use of Xarelto. The researchers note that all three patients were tapering off another anticoagulant at the time of their ...
According to the Madison Record, a $4.35 million Madison County Xarelto lawsuit has been transferred to the multidistrict litigation court, where it joins roughly 250 similar Xarelto lawsuits. The lawsuit stems from a 90-count complaint filed in January against the various companies responsible for Xarelto, including Bayer and Johnson & Johnson’s Janssen Pharmaceuticals. The plaintiff has accused the manufacturers of Xarelto of overstating the efficacy of their drug ...
